Clinical Scorecard: Concurrent Tuberculous Meningoencephalitis and Autoimmune GFAP Astrocytopathy: A Case Study

At a Glance

Key Highlights

• Co-existence of tuberculous meningoencephalitis and GFAP astrocytopathy is rare.
• Clinical features and CSF profiles can overlap, leading to misdiagnosis.
• Diagnosis confirmed through CSF analysis and imaging studies.
• Patient showed improvement with antitubercular drugs and corticosteroids.
• Therapeutic paradoxical reactions may occur, visible on imaging.

Guideline-Based Recommendations

Diagnosis

• Utilize CSF analysis for pleocytosis, protein levels, glucose, and chloride.
• Confirm tuberculous meningoencephalitis with GeneXpert MTB/RIF.

Management

• Administer concomitant anti-infective and immunomodulatory therapy.
• Consider timing of steroid tapering and discontinuation.

Monitoring & Follow-up

• Regular follow-up imaging to assess changes in lesions.
• Monitor clinical symptoms for potential therapeutic paradoxical reactions.

Risks

• Delay in treatment associated with high mortality and disability.
• Potential for worsening symptoms upon steroid discontinuation.

Patient & Prescribing Data

Older adults with neurological symptoms and signs of CNS infection.

Combination therapy with antitubercular drugs and corticosteroids is essential.

Clinical Best Practices

• Early recognition of overlapping symptoms of CNS infections and autoimmune conditions.
• Thorough CSF analysis to differentiate between conditions.
• Close monitoring of clinical and radiological responses to treatment.

Related Resources & Content

• Case Study Reference